Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • tdyo
    Junior Member
    • Feb 2013
    • 7

    #1

    Transcript Length Bias in Differential Expression Analysis [DESeq]

    Hi everyone,

    Is there a standard approach to addressing transcript length bias in gene expression? I have come across the window approach provided by Oshlack & Wakefield (2012), but not much else.

    I have run Bowtie2 with insert restrictions, ignoring discordant alignments, and removed reads that are not uniquely aligned afterwards (resulting in a uniquely aligned, concordant SAM file). Following this, I ran the SAM file through htseq-count and DESeq. The following graph shows the significant relationship between scaffold length and the BaseMean Expression provided by DESeq (the p-value is very low, but the R2 is also very low). Any thoughts? Thanks for any input!

  • chadn737
    Senior Member
    • Jan 2009
    • 392

    #2
    What exactly are you trying to do? You are asking a very general broad question with no clear indication as to why transcript length is a factor in your analysis. For instance if you are simply comparing the expression of the SAME gene under two different conditions (the standard usage of DESeq) than transcript length is not a factor since you are comparing transcripts of the same length.

    Comment

    • tdyo
      Junior Member
      • Feb 2013
      • 7

      #3
      Yes, I am comparing the expression of the same transcript to itself between two groups of individuals under different treatments (looking for differentially expressed genes)... well that makes sense. Now I feel silly - thanks for the insight.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      43 views
      0 reactions
      Last Post SEQadmin2  
      Working...